JP2010525044A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010525044A5 JP2010525044A5 JP2010504834A JP2010504834A JP2010525044A5 JP 2010525044 A5 JP2010525044 A5 JP 2010525044A5 JP 2010504834 A JP2010504834 A JP 2010504834A JP 2010504834 A JP2010504834 A JP 2010504834A JP 2010525044 A5 JP2010525044 A5 JP 2010525044A5
- Authority
- JP
- Japan
- Prior art keywords
- product
- treatment
- progestin
- muscle loss
- megestrol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 claims 5
- 229940124748 beta 2 agonist Drugs 0.000 claims 5
- 210000003205 muscle Anatomy 0.000 claims 5
- 239000000583 progesterone congener Substances 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 4
- 229960001786 megestrol Drugs 0.000 claims 4
- RQZAXGRLVPAYTJ-GQFGMJRRSA-N megestrol acetate Chemical compound C1=C(C)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 RQZAXGRLVPAYTJ-GQFGMJRRSA-N 0.000 claims 4
- 230000002265 prevention Effects 0.000 claims 4
- 239000003120 macrolide antibiotic agent Substances 0.000 claims 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 2
- 208000030507 AIDS Diseases 0.000 claims 1
- 206010006895 Cachexia Diseases 0.000 claims 1
- 239000003246 corticosteroid Substances 0.000 claims 1
- 229960002848 formoterol Drugs 0.000 claims 1
- BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical group C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 claims 1
- 229940041033 macrolides Drugs 0.000 claims 1
- 229960002985 medroxyprogesterone acetate Drugs 0.000 claims 1
- PSGAAPLEWMOORI-PEINSRQWSA-N medroxyprogesterone acetate Chemical compound C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](OC(C)=O)(C(C)=O)CC[C@H]21 PSGAAPLEWMOORI-PEINSRQWSA-N 0.000 claims 1
- 208000001076 sarcopenia Diseases 0.000 claims 1
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0707931.2 | 2007-04-24 | ||
| GB0707930.4 | 2007-04-24 | ||
| GB0707930A GB0707930D0 (en) | 2007-04-24 | 2007-04-24 | New therapeutic use |
| GB0707931A GB0707931D0 (en) | 2007-04-24 | 2007-04-24 | New Therapeutic use |
| GB0710101A GB0710101D0 (en) | 2007-05-25 | 2007-05-25 | New Therapeutic use |
| GB0710101.7 | 2007-05-25 | ||
| PCT/GB2008/001452 WO2008129308A2 (en) | 2007-04-24 | 2008-04-24 | Drug combination and its use in the treatment of muscle loss |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010525044A JP2010525044A (ja) | 2010-07-22 |
| JP2010525044A5 true JP2010525044A5 (enExample) | 2011-05-06 |
| JP5627452B2 JP5627452B2 (ja) | 2014-11-19 |
Family
ID=39639100
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010504834A Expired - Fee Related JP5627452B2 (ja) | 2007-04-24 | 2008-04-24 | 筋肉減少の治療に使用される薬剤の組合せ |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8653052B2 (enExample) |
| EP (1) | EP2155180B1 (enExample) |
| JP (1) | JP5627452B2 (enExample) |
| KR (1) | KR101546977B1 (enExample) |
| CN (2) | CN101730547A (enExample) |
| AU (1) | AU2008240379B2 (enExample) |
| BR (1) | BRPI0810461A2 (enExample) |
| CA (1) | CA2721739C (enExample) |
| DK (1) | DK2155180T3 (enExample) |
| EA (1) | EA018918B1 (enExample) |
| ES (1) | ES2592289T3 (enExample) |
| HK (1) | HK1202262A1 (enExample) |
| IL (1) | IL201426A (enExample) |
| MX (1) | MX2009011294A (enExample) |
| NZ (1) | NZ580975A (enExample) |
| WO (1) | WO2008129308A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7417038B1 (en) | 1998-10-15 | 2008-08-26 | Imperial Innovations Limited | Methods of treating cachexia |
| BRPI0613034A8 (pt) | 2005-07-14 | 2018-01-02 | Lipothera Inc | formulação injetável para acúmulo de tecido adiposo, formulação injetável e método para o tratamento de acúmulo de gordura, e, método para reduzir o tecido adiposo. |
| GB0624282D0 (en) | 2006-12-05 | 2007-01-10 | Cavalla David | Treatment of cachexia |
| WO2012074856A2 (en) * | 2010-11-24 | 2012-06-07 | Lithera, Inc. | Selective, lipophilic, and long-acting beta agonist monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging |
| MX377481B (es) * | 2014-08-05 | 2025-03-07 | Raqualia Pharma Inc | Derivados de serina como agonistas del receptor de grelina. |
| JP7353687B2 (ja) * | 2020-01-13 | 2023-10-02 | アストロメディカル・バイオテクノロジー・リミテッド | 悪液質の治療におけるケタミンの使用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0308157B1 (en) | 1987-09-15 | 1997-02-26 | The Rowett Research Institute | Therapeutic applications of beta-adrenergic agonists |
| ES2380318T3 (es) * | 2002-04-12 | 2012-05-10 | Alkermes Pharma Ireland Limited | Formulaciones nanoparticulares de megestrol |
| US7101576B2 (en) * | 2002-04-12 | 2006-09-05 | Elan Pharma International Limited | Nanoparticulate megestrol formulations |
| ES2245612B1 (es) | 2004-06-29 | 2007-08-16 | Universidad De Barcelona | Nuevo uso terapeutico del formoterol. |
| EP1991270A4 (en) | 2005-12-22 | 2009-12-02 | Anaborex Inc | COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF CACHEXIA |
| US7947579B2 (en) | 2006-02-13 | 2011-05-24 | Stc.Unm | Method of making dense, conformal, ultra-thin cap layers for nanoporous low-k ILD by plasma assisted atomic layer deposition |
-
2008
- 2008-04-24 BR BRPI0810461-1A2A patent/BRPI0810461A2/pt not_active IP Right Cessation
- 2008-04-24 AU AU2008240379A patent/AU2008240379B2/en not_active Ceased
- 2008-04-24 DK DK08737103.5T patent/DK2155180T3/en active
- 2008-04-24 CN CN200880012990A patent/CN101730547A/zh active Pending
- 2008-04-24 WO PCT/GB2008/001452 patent/WO2008129308A2/en not_active Ceased
- 2008-04-24 EA EA200970957A patent/EA018918B1/ru not_active IP Right Cessation
- 2008-04-24 MX MX2009011294A patent/MX2009011294A/es active IP Right Grant
- 2008-04-24 EP EP08737103.5A patent/EP2155180B1/en not_active Not-in-force
- 2008-04-24 JP JP2010504834A patent/JP5627452B2/ja not_active Expired - Fee Related
- 2008-04-24 NZ NZ580975A patent/NZ580975A/xx not_active IP Right Cessation
- 2008-04-24 CA CA2721739A patent/CA2721739C/en not_active Expired - Fee Related
- 2008-04-24 US US12/594,985 patent/US8653052B2/en not_active Expired - Fee Related
- 2008-04-24 ES ES08737103.5T patent/ES2592289T3/es active Active
- 2008-04-24 CN CN201410490740.8A patent/CN104306381A/zh active Pending
- 2008-04-24 KR KR1020097024247A patent/KR101546977B1/ko not_active Expired - Fee Related
-
2009
- 2009-10-11 IL IL201426A patent/IL201426A/en not_active IP Right Cessation
-
2015
- 2015-03-19 HK HK15102807.2A patent/HK1202262A1/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010525044A5 (enExample) | ||
| JP2015500225A5 (enExample) | ||
| JP2010510212A5 (enExample) | ||
| FR2926553B1 (fr) | Derives d'indole-2-carboxamides et d'azaindole-2- carboxamides substitues par un groupe silanyle, leur preparation et leur application en therapeutique | |
| CL2007001993A1 (es) | Compuestos derivados de pirimidilciclopentanos hidroxilados y metoxilados; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de una enfermedad inflamatoria, hiperproliferante, cardiovascular, neurodegenerat | |
| JP2016539134A5 (enExample) | ||
| JP2016536341A5 (enExample) | ||
| EP4342540A3 (en) | Substituted heterocyclyl derivatives as cdk inhibitors | |
| IL209121A (en) | Indazolil history, their medicinal preparations and their use in the preparation of medications for the treatment of inflammatory diseases | |
| WO2007101224A3 (en) | Inhibitors of the unfolded protein response and methods for their use | |
| WO2015160975A3 (en) | Combination of a pi3k inhibitor with a bcl-2 inhibitor for use in the treatment of cancer | |
| CL2007000806A1 (es) | Compuestos derivados de heteropentaciclos sustituidos; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento del cancer. | |
| WO2007088123A3 (en) | Use of nitrooxyderivative of drug for the treatment of muscular dystrophies | |
| CL2007001992A1 (es) | Compuestos derivados de pirimidilciclopentanos; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de una enfermedad inflamatoria, hiperproliferante, cardiovascular, neurodege | |
| JP2007523049A5 (enExample) | ||
| IL199945A (en) | Hydrochloric acid derivatives, pharmaceuticals containing them and their use in the preparation of drugs | |
| IL198657A0 (en) | Use of compositions comprising capsaicinoid compunds in the preparation of medicaments and as medicaments for the treatment of keratoconjunctivitis sicca | |
| CL2012003340A1 (es) | Composicion farmaceutica de administracion oral de bendamustina y su uso en el tratamiento oral de una condicion medica seleccionada de leucemia linfocitica cronica, cancer de mama, entre otras. | |
| ZA201206360B (en) | Solid composition for the oral administration of dyes and diagnostic use thereof | |
| EP2925340A4 (en) | Pharmaceutical compositions and therapeutic methods of use comprising selective agonists of melanocortin 1 receptor | |
| WO2007116102A3 (en) | Therapeutic composition and use | |
| WO2009013237A3 (en) | Stable solid pharmaceutical composition comprising candesartan or pharmaceutically acceptable forms thereof | |
| CL2008000957A1 (es) | Compuestos derivados de heterociclos nitrogenados, composicion farmaceutica; procedimiento de preparacion; y su uso en trastornos del sueno; tales como apnea nocturna, narcolepsia, insomnio y parasomnia, entre otros. | |
| CL2008000965A1 (es) | Composicion farmaceutica que comprende un agente antiinflamatorio no esteroideo y un analgesico opiaceo, y su uso para el tratamiento del dolor. | |
| NZ580975A (en) | Drug combination of beta 2 agonist and a progestin for the treatment of muscle loss |